We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


New Results Reveal Competitive Advantages of VitroGrow™ Stem Cell Culture Media

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "New Results Reveal Competitive Advantages of VitroGrow™ Stem Cell Culture Media"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Vitro Diagnostics, Inc. has announced completion of studies comparing its mesenchymal stem cell culture media, VitroGrow™, to major competitors showing distinct performance improvements over competing products.

These new results showed that VitroGrow™ consistently improved mesenchymal stem cell growth, quality, potency and cellular recovery over leading competitors including comparable products sold by InVitrogen, Lonza and Stem Cell Technologies.

Furthermore, VitroGrow™ also exhibits real-time stability that exceeds 1 year while competitors published recommended usage periods are 2 weeks to 4 weeks, thus resulting in substantial cost savings and expanded usage opportunities to VitroGrow™ customers.